| scholarly article | Q13442814 |
| P356 | DOI | 10.1152/AJPCELL.00149.2015 |
| P698 | PubMed publication ID | 26084306 |
| P50 | author | Frédéric Perros | Q56606126 |
| Fabrice Antigny | Q57130685 | ||
| Benoit Ranchoux | Q85397193 | ||
| Steeve Provencher | Q92750879 | ||
| P2093 | author name string | Jolyane Meloche | |
| Sébastien Bonnet | |||
| Ian Johnson | |||
| Sandra Breuils-Bonnet | |||
| François Potus | |||
| Eve Tremblay | |||
| Marie Le Guen | |||
| Jérôme Vinck | |||
| P433 | issue | 6 | |
| P921 | main subject | arterial hypertension | Q41861 |
| P304 | page(s) | C363-72 | |
| P577 | publication date | 2015-06-17 | |
| P1433 | published in | American Journal of Physiology - Cell Physiology | Q2227080 |
| P1476 | title | miR-223 reverses experimental pulmonary arterial hypertension | |
| P478 | volume | 309 |
| Q33788516 | Assessment of microRNA and gene dysregulation in pulmonary hypertension by endoarterial biopsy |
| Q57070238 | Bone morphogenetic protein signaling is required for RAD51-mediated maintenance of genome integrity in vascular endothelial cells |
| Q97533968 | Cocaine-regulated microRNA miR-124 controls poly (ADP-ribose) polymerase-1 expression in neuronal cells |
| Q27005594 | DNA Damage and Pulmonary Hypertension |
| Q88778854 | Dipeptidyl peptidase IV (DPP-4) inhibition alleviates pulmonary arterial remodeling in experimental pulmonary hypertension |
| Q37677437 | Discerning functional hierarchies of microRNAs in pulmonary hypertension |
| Q49882973 | Dual ETA/ETB blockade with macitentan improves both vascular remodeling and angiogenesis in pulmonary arterial hypertension |
| Q58588641 | Elucidating the contributory role of microRNA to cardiovascular diseases (a review) |
| Q64100292 | Exosome-orchestrated hypoxic tumor microenvironment |
| Q40972077 | HDAC6: A Novel Histone Deacetylase Implicated in Pulmonary Arterial Hypertension |
| Q92025828 | HDL Cholesterol as a Marker of Disease Severity and Prognosis in Patients with Pulmonary Arterial Hypertension |
| Q42114115 | Identifying microRNAs targeting Wnt/β-catenin pathway in end-stage idiopathic pulmonary arterial hypertension |
| Q47655572 | Inhibition of miR-361-5p suppressed pulmonary artery smooth muscle cell survival and migration by targeting ABCA1 and inhibiting the JAK2/STAT3 pathway |
| Q58593702 | Insights on the epigenetic mechanisms underlying pulmonary arterial hypertension |
| Q90166176 | Methylglyoxal-induced miR-223 suppresses rat vascular KATP channel activity by downregulating Kir6.1 mRNA in carbonyl stress |
| Q94453346 | MicroRNA and mRNA analysis of angiotensin II-induced renal artery endothelial cell dysfunction |
| Q91689672 | MicroRNA-146a improves sepsis-induced cardiomyopathy by regulating the TLR-4/NF-κB signaling pathway |
| Q38685512 | MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension |
| Q36845623 | MicroRNA-223 Attenuates Hypoxia-induced Vascular Remodeling by Targeting RhoB/MLC2 in Pulmonary Arterial Smooth Muscle Cells |
| Q52613070 | MicroRNA-223 protects neonatal rat cardiomyocytes and H9c2 cells from hypoxia-induced apoptosis and excessive autophagy via the Akt/mTOR pathway by targeting PARP-1. |
| Q33808938 | MicroRNAs Modulate Oxidative Stress in Hypertension through PARP-1 Regulation |
| Q26775547 | MicroRNAs and Endothelial (Dys) Function |
| Q37733659 | MicroRNAs in heart failure: Non-coding regulators of metabolic function |
| Q92281209 | Mir-455-3p-1 represses FGF7 expression to inhibit pulmonary arterial hypertension through inhibiting the RAS/ERK signaling pathway |
| Q38676413 | Molecular pathogenesis and current pathology of pulmonary hypertension |
| Q92228165 | Noncoding RNAs in Hypertension |
| Q38816280 | Noncoding RNAs in smooth muscle cell homeostasis: implications in phenotypic switch and vascular disorders |
| Q52592452 | PAI-1 is a novel component of the miR-17~92 signaling that regulates pulmonary artery smooth muscle cell phenotypes. |
| Q61810180 | Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives |
| Q41455982 | Poly (ADP-Ribose) Polymerase-1 (PARP-1) Induction by Cocaine Is Post-Transcriptionally Regulated by miR-125b. |
| Q57295264 | Recent research progress of microRNAs in hypertension pathogenesis, with a focus on the roles of miRNAs in pulmonary arterial hypertension |
| Q90207862 | Role of miR-223-3p in pulmonary arterial hypertension via targeting ITGB3 in the ECM pathway |
| Q90250650 | Targeting epigenetic mechanisms as an emerging therapeutic strategy in pulmonary hypertension disease |
| Q91653814 | The Search for Disease-Modifying Therapies in Pulmonary Hypertension |
| Q33788493 | The cancer theory of pulmonary arterial hypertension |
| Q58693105 | The diagnostic values of circulating miRNAs for hypertension and bioinformatics analysis |
| Q38827976 | The emerging role of microRNAs in hypoxia-induced pulmonary hypertension |
| Q109294757 | Therapeutic Significance of microRNA-Mediated Regulation of PARP-1 in SARS-CoV-2 Infection |
| Q49312062 | Translational Advances in the Field of Pulmonary Hypertension. Translating MicroRNA Biology in Pulmonary Hypertension. It Will Take More Than "miR" Words |
| Q89519689 | Upregulation of miR-335-3p by NF-κB Transcriptional Regulation Contributes to the Induction of Pulmonary Arterial Hypertension via APJ during Hypoxia |
| Q40272717 | Wnt5a is elevated in heart failure and affects cardiac fibroblast function |
| Q38764391 | miRNA-34a promotes proliferation of human pulmonary artery smooth muscle cells by targeting PDGFRA. |
| Q38668258 | microRNA and Pulmonary Hypertension |
Search more.